Picard Medical Inc. released its financial results for the quarter ending June 30, 2025. The company reported an increase in total revenues to $2.131 million, up from $0.694 million in the same period of 2024, marking a 207% increase. The revenue growth was entirely driven by product sales, as rental revenues remained unchanged. The cost of revenues also rose, reaching $2.258 million from $1.076 million in the previous year, an increase of 110%. This includes a 116% rise in the cost of products and a 97% rise in rental costs. Picard Medical Inc. indicated expectations to incur increased costs associated with establishing sales, marketing, and revenue growth. The company did not provide specific guidance or outlook figures for future periods in the report.